Transdermal rivastigmine in the treatment of Alzheimer’s disease: current and future directions

Efficacy of Higher Dose 13.3 mg/24 h Rivastigmine Patch on Instrumental Activities of Daily Living in Patients with Mild-to-Moderate Alzheimer's Disease

(2013) George Grossberg et al.   American Journal of Alzheimers Disease and Other Dementias

Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer’s disease: the EMBRACE study

(2013) Serge Gauthier et al.   CURRENT MEDICAL RESEARCH AND OPINION

Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration

(2013) Zhen-Zhen Yang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Randomized, Double-Blind, Parallel-Group, 48-Week Study for Efficacy and Safety of a Higher-Dose Rivastigmine Patch (15 vs. 10 cm2) in Alzheimer’s Disease

(2012) Jeffrey Cummings et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Which psychotropic medications induce hepatotoxicity?

(2011) Karim Sedky et al.   GENERAL HOSPITAL PSYCHIATRY

Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment

(2010) Carina Wattmo et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimerʼs Disease

(2009) Nazem Bassil et al.   CNS DRUGS

Different Cholinesterase Inhibitor Effects on CSF Cholinesterases in Alzheimer Patients

(2009) Agneta Nordberg et al.   Current Alzheimer Research

Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: a review

(2009) A. Kurz et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Atividade física sistematizada e desempenho cognitivo em idosos com demência de Alzheimer: uma revisão sistemática

(2009) Flávia Gomes de Melo Coelho et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Possible Role of Hydroxylated Metabolites of Tacrine in Drug Toxicity and Therapy of Alzheimers Disease

(2008) Jiri Patocka et al.   CURRENT DRUG METABOLISM